{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:55:13Z","timestamp":1793105713857,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Schizophr"],"DOI":"10.1038\/s41537-025-00711-0","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T03:16:14Z","timestamp":1765250174000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Alterations in serum IL-10 and IL-19 levels in drug-na\u00efve first-episode adolescent-onset schizophrenia and their associations with clinical symptoms"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8625-5474","authenticated-orcid":false,"given":"Haidong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingshu","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0577-5951","authenticated-orcid":false,"given":"Xiaobin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"711_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S0140-6736(21)01730-X","volume":"399","author":"S Jauhar","year":"2022","unstructured":"Jauhar, S., Johnstone, M. & McKenna, P. J. Schizophrenia. Lancet 399, 473\u2013486 (2022).","journal-title":"Lancet"},{"key":"711_CR2","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.schres.2022.11.010","volume":"250","author":"I-M Molstrom","year":"2022","unstructured":"Molstrom, I.-M. et al. The prognosis of schizophrenia: a systematic review and meta-analysis with meta-regression of 20-year follow-up studies. Schizophr. Res. 250, 152\u2013163 (2022).","journal-title":"Schizophr. Res."},{"key":"711_CR3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","volume":"9","author":"GBD","year":"2022","unstructured":"GBD Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry 9, 137\u2013150 (2022).","journal-title":"Lancet Psychiatry"},{"key":"711_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.euroneuro.2024.02.005","volume":"82","author":"CU Correll","year":"2024","unstructured":"Correll, C. U. et al. Identification and treatment of individuals with childhood-onset and early-onset schizophrenia. Eur. Neuropsychopharmacol. 82, 57\u201371 (2024).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"711_CR5","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1001\/jamapsychiatry.2024.4941","volume":"82","author":"L Dudeck","year":"2025","unstructured":"Dudeck, L. et al. Differences in Blood Leukocyte Subpopulations in Schizophrenia: a systematic review and meta-analysis. JAMA Psychiatry 82, 492\u2013504 (2025).","journal-title":"JAMA Psychiatry"},{"key":"711_CR6","doi-asserted-by":"crossref","unstructured":"Lv, H., Guo, M., Guo, C. & He, K. The interrelationships between cytokines and schizophrenia: a systematic review. Int. J. Mol. Sci. 25, 8477 (2024).","DOI":"10.3390\/ijms25158477"},{"key":"711_CR7","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1038\/s41380-022-01582-y","volume":"27","author":"M Morrens","year":"2022","unstructured":"Morrens, M. et al. The relationship between immune and cognitive dysfunction in mood and psychotic disorder: a systematic review and a meta-analysis. Mol. Psychiatry 27, 3237\u20133246 (2022).","journal-title":"Mol. Psychiatry"},{"key":"711_CR8","doi-asserted-by":"crossref","unstructured":"Speers, L. J. & Bilkey, D. K. Inflammation in Schizophrenia: the role of disordered oscillatory mechanisms. Cells 14, 650 (2025).","DOI":"10.3390\/cells14090650"},{"key":"711_CR9","doi-asserted-by":"crossref","unstructured":"Saxton, R. A. et al. Structure-based decoupling of the pro- and anti-inflammatory functions of interleukin-10. Science 371, eabc8433 (2021).","DOI":"10.1126\/science.abc8433"},{"key":"711_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-024-06163-7","volume":"24","author":"X Zhao","year":"2024","unstructured":"Zhao, X. et al. Effects of 6-week olanzapine treatment on serum IL-2, IL-4, IL-8, IL-10, and TNF-\u03b1 levels in drug-naive individuals with first-episode schizophrenia. BMC Psychiatry 24, 703 (2024).","journal-title":"BMC Psychiatry"},{"key":"711_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2023.148667","volume":"1822","author":"T Beatriz Gonz\u00e1lez-Castro","year":"2024","unstructured":"Beatriz Gonz\u00e1lez-Castro, T. et al. The association of cytokines genes (IL-6 and IL-10) with the susceptibility to schizophrenia: a systematic review and meta-analysis. Brain Res. 1822, 148667 (2024).","journal-title":"Brain Res."},{"key":"711_CR12","doi-asserted-by":"crossref","unstructured":"Guo, T. et al. Variations in inflammatory regulators in male patients with chronic schizophrenia associated with psychopathology and cognitive deficits. BMC Psychiatry 24, 811 (2024).","DOI":"10.1186\/s12888-024-06288-9"},{"key":"711_CR13","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.cytogfr.2010.08.003","volume":"21","author":"A Zdanov","year":"2010","unstructured":"Zdanov, A. Structural analysis of cytokines comprising the IL-10 family. Cytokine Growth Factor Rev. 21, 325\u2013330 (2010).","journal-title":"Cytokine Growth Factor Rev."},{"key":"711_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2174\/1874467213666200424151528","volume":"14","author":"Y Fujimoto","year":"2021","unstructured":"Fujimoto, Y., Kuramoto, N., Yoneyama, M. & Azuma, Y. T. Interleukin-19 as an Immunoregulatory Cytokine. Curr. Mol. Pharmacol. 14, 191\u2013199 (2021).","journal-title":"Curr. Mol. Pharmacol."},{"key":"711_CR15","doi-asserted-by":"crossref","unstructured":"Fei, C. et al. Comparative analysis of salivary and serum inflammatory mediator profiles in patients with rheumatoid arthritis and periodontitis. Mediat. Inflamm. 2025, 7739833 (2025).","DOI":"10.1155\/mi\/7739833"},{"key":"711_CR16","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1007\/s12031-020-01602-y","volume":"70","author":"S Sangsefidi","year":"2020","unstructured":"Sangsefidi, S. et al. High levels of Il-19 in patients with chronic inflammatory demyelinating polyneuropathy. J. Mol. Neurosci. 70, 1997\u20132000 (2020).","journal-title":"J. Mol. Neurosci."},{"key":"711_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.pnpbp.2013.12.006","volume":"50","author":"S Okazaki","year":"2014","unstructured":"Okazaki, S. et al. Association analysis of putative cis-acting polymorphisms of interleukin-19 gene with schizophrenia. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 50, 151\u2013156 (2014).","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"711_CR18","doi-asserted-by":"crossref","unstructured":"Szota, A. M. et al. Effect of Electroconvulsive Therapy (ECT) on IL-1\u03b2, IP-10, IL-17, TNF\u03b1, IL-10 and Soluble IL-2 Receptor in Treatment-Resistant Schizophrenia (TRS) patients\u2014a preliminary study. J. Clin. Med. 14, 3170 (2025).","DOI":"10.3390\/jcm14093170"},{"key":"711_CR19","doi-asserted-by":"publisher","first-page":"484","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_212_22","volume":"64","author":"V Golimbet","year":"2022","unstructured":"Golimbet, V. et al. A study of the association between polymorphisms in the genes for interleukins IL-6 and IL-10 and negative symptoms subdomains in schizophrenia. Indian J. psychiatry 64, 484\u2013488 (2022).","journal-title":"Indian J. psychiatry"},{"key":"711_CR20","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00213-022-06067-y","volume":"239","author":"X Yuan","year":"2022","unstructured":"Yuan, X. et al. Pro-inflammatory cytokine levels are elevated in female patients with schizophrenia treated with clozapine. Psychopharmacology 239, 765\u2013771 (2022).","journal-title":"Psychopharmacology"},{"key":"711_CR21","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41537-023-00398-1","volume":"9","author":"H Kim","year":"2023","unstructured":"Kim, H. et al. Inflammatory markers of symptomatic remission at 6\u2009months in patients with first-episode schizophrenia. Schizophrenia 9, 68 (2023).","journal-title":"Schizophrenia"},{"key":"711_CR22","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.biopsych.2020.06.028","volume":"89","author":"PK Patel","year":"2021","unstructured":"Patel, P. K., Leathem, L. D., Currin, D. L. & Karlsgodt, K. H. Adolescent neurodevelopment and vulnerability to psychosis. Biol. Psychiatry 89, 184\u2013193 (2021).","journal-title":"Biol. Psychiatry"},{"key":"711_CR23","doi-asserted-by":"crossref","unstructured":"Yin, B. et al. Identifying plasma metabolic characteristics of major depressive disorder, bipolar disorder, and schizophrenia in adolescents. Transl. Psychiatry 14, 163 (2024).","DOI":"10.1038\/s41398-024-02886-z"},{"key":"711_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.schres.2014.03.024","volume":"156","author":"MH Xiu","year":"2014","unstructured":"Xiu, M. H. et al. Decreased interleukin-10 serum levels in first-episode drug-na\u00efve schizophrenia: relationship to psychopathology. Schizophr. Res. 156, 9\u201314 (2014).","journal-title":"Schizophr. Res."},{"key":"711_CR25","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S2215-0366(23)00025-1","volume":"10","author":"S Halstead","year":"2023","unstructured":"Halstead, S. et al. Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis. Lancet Psychiatry 10, 260\u2013271 (2023).","journal-title":"Lancet Psychiatry"},{"key":"711_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2024.111166","volume":"136","author":"TH Zhang","year":"2024","unstructured":"Zhang, T. H. et al. Associations between cytokine levels and cognitive function among individuals at clinical high risk for psychosis. Prog. Neuropsychopharmacol. Biol. Psychiatry 136, 111166 (2024).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"711_CR27","doi-asserted-by":"crossref","unstructured":"Victor, J. R. & Nahm, D.-H. Mechanism underlying polyvalent IgG-induced regulatory T cell activation and its clinical application: anti-idiotypic regulatory T cell theory for immune tolerance. Front. Immunol. 14, 1242860 (2023).","DOI":"10.3389\/fimmu.2023.1242860"},{"key":"711_CR28","doi-asserted-by":"crossref","unstructured":"Martinez-Espinosa, I., Serrato, J. A. & Ortiz-Quintero, B. Role of IL-10-producing natural killer cells in the regulatory mechanisms of inflammation during systemic infection. Biomolecules 12, 4 (2021).","DOI":"10.3390\/biom12010004"},{"key":"711_CR29","doi-asserted-by":"crossref","unstructured":"Pinti, M. et al. A comprehensive analysis of cytokine network in centenarians. Int. J. Mol. Sci. 24, 2719 (2023).","DOI":"10.3390\/ijms24032719"},{"key":"711_CR30","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1007\/s13555-024-01262-5","volume":"14","author":"IM Catlett","year":"2024","unstructured":"Catlett, I. M., Gao, L., Hu, Y., Banerjee, S. & Krueger, J. G. Pharmacodynamic response to deucravacitinib, an oral, selective, allosteric TYK2 inhibitor, in a global, phase 2, randomized, double-blind, placebo-controlled psoriasis trial. Dermatol. Ther. 14, 2827\u20132839 (2024).","journal-title":"Dermatol. Ther."},{"key":"711_CR31","doi-asserted-by":"crossref","unstructured":"Li, Q. et al. The colonic interleukin-19 aggravates the dextran sodium sulfate\/stress-induced comorbidities due to colitis and anxiety. Front. Immunol. 14, 1153344 (2023).","DOI":"10.3389\/fimmu.2023.1153344"},{"key":"711_CR32","doi-asserted-by":"crossref","unstructured":"Malashenkova, I. K. et al. Neuro-immune aspects of schizophrenia with severe negative symptoms: new diagnostic markers of disease phenotype. Sovrem. Tehnol. v Med. 13 (2021).","DOI":"10.17691\/stm2021.13.6.03"},{"key":"711_CR33","doi-asserted-by":"crossref","unstructured":"Binic, I. et al. Clinical relevance of peripheral interleukins in drug-naive first-episode psychosis: symptom-specific associations from the PANSS dimensions. Brain Sci. 15, 932 (2025).","DOI":"10.3390\/brainsci15090932"},{"key":"711_CR34","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s11011-020-00619-x","volume":"36","author":"RF Mousa","year":"2020","unstructured":"Mousa, R. F., Al-Hakeim, H. K., Alhaideri, A. & Maes, M. Chronic fatigue syndrome and fibromyalgia-like symptoms are an integral component of the phenome of schizophrenia: neuro-immune and opioid system correlates. Metab. Brain Dis. 36, 169\u2013183 (2020).","journal-title":"Metab. Brain Dis."},{"key":"711_CR35","doi-asserted-by":"crossref","unstructured":"Hoprekstad, G. E. et al. Association between cytokines and suicidality in patients with psychosis: a multicentre longitudinal analysis. Brain Behav. Immunity Health 37, 100756 (2024).","DOI":"10.1016\/j.bbih.2024.100756"},{"key":"711_CR36","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.schres.2022.12.049","volume":"252","author":"GE Hoprekstad","year":"2023","unstructured":"Hoprekstad, G. E. et al. Depression trajectories and cytokines in schizophrenia spectrum disorders - A longitudinal observational study. Schizophr. Res. 252, 77\u201387 (2023).","journal-title":"Schizophr. Res."},{"key":"711_CR37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.biopsycho.2014.07.005","volume":"102","author":"TW Smith","year":"2014","unstructured":"Smith, T. W., Uchino, B. N., Bosch, J. A. & Kent, R. G. Trait hostility is associated with systemic inflammation in married couples: an actor\u2013partner analysis. Biol. Psychol. 102, 51\u201353 (2014).","journal-title":"Biol. Psychol."},{"key":"711_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2022.110534","volume":"116","author":"X Chen","year":"2022","unstructured":"Chen, X. et al. Systemic inflammatory regulators and 7 major psychiatric disorders: a two-sample Mendelian randomization study. Prog. Neuropsychopharmacol. Biol. Psychiatry 116, 110534 (2022).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"711_CR39","doi-asserted-by":"crossref","unstructured":"Yuan, N., Chen, Y., Xia, Y., Dai, J. & Liu, C. Inflammation-related biomarkers in major psychiatric disorders: a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses. Transl. Psychiatry 9, 233 (2019).","DOI":"10.1038\/s41398-019-0570-y"},{"key":"711_CR40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ijpsycho.2017.02.001","volume":"114","author":"Q Zhang","year":"2017","unstructured":"Zhang, Q. et al. Increased ratio of high sensitivity C-reactive protein to interleukin-10 as a potential peripheral biomarker of schizophrenia and aggression. Int. J. Psychophysiol 114, 9\u201315 (2017).","journal-title":"Int. J. Psychophysiol"},{"key":"711_CR41","doi-asserted-by":"crossref","unstructured":"Wang, X. et al. Relationship between plasma TNF-\u03b1 levels and agitation symptoms in first episode patients with schizophrenia. BMC Psychiatry 24, 480 (2024).","DOI":"10.1186\/s12888-024-05796-y"},{"key":"711_CR42","doi-asserted-by":"crossref","unstructured":"Dong, Y. et al. Role of peripheral cytokines and orbitofrontal cortex subregion structure in schizophrenia agitation. Sci. Rep. 15, 14125 (2025).","DOI":"10.1038\/s41598-025-99033-5"},{"key":"711_CR43","doi-asserted-by":"crossref","unstructured":"Kaya, S. et al. Examination of the relationship between peripheral inflammation markers and impulsivity and aggression in schizophrenia patients involved and not involved in crime. J. Pers. Med. 13, 475 (2023).","DOI":"10.3390\/jpm13030475"},{"key":"711_CR44","doi-asserted-by":"publisher","first-page":"e710","DOI":"10.1016\/S2665-9913(22)00198-9","volume":"4","author":"GA Robinson","year":"2022","unstructured":"Robinson, G. A. et al. Investigating sex differences in T regulatory cells from cisgender and transgender healthy individuals and patients with autoimmune inflammatory disease: a cross-sectional study. Lancet Rheumatol. 4, e710\u2013e724 (2022).","journal-title":"Lancet Rheumatol."},{"key":"711_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2022.110642","volume":"120","author":"E Guma","year":"2023","unstructured":"Guma, E. et al. Investigating the \u201ctwo-hit hypothesis\u201d: effects of prenatal maternal immune activation and adolescent cannabis use on neurodevelopment in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 120, 110642 (2023).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"711_CR46","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1089\/cap.2020.0052","volume":"31","author":"TR Rice","year":"2021","unstructured":"Rice, T. R. & Walther, A. Male-specific metabolic considerations concerning the prescription of second-generation antipsychotics to adolescents. J. Child Adolesc. Psychopharmacol. 31, 53\u201355 (2021).","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"711_CR47","doi-asserted-by":"crossref","unstructured":"He, J. et al. Sex differences in the association of treatment-resistant schizophrenia and serum interleukin-6 levels. BMC Psychiatry 23, 470 (2023).","DOI":"10.1186\/s12888-023-04952-0"},{"key":"711_CR48","doi-asserted-by":"publisher","first-page":"836","DOI":"10.3390\/brainsci13050836","volume":"13","author":"E Ermakov","year":"2023","unstructured":"Ermakov, E. et al. Association of peripheral inflammatory biomarkers and growth factors levels with sex, therapy and other clinical factors in Schizophrenia and patient stratification based on these data. Brain Sci 13, 836 (2023).","journal-title":"Brain Sci"},{"key":"711_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00787-025-02709-6","volume":"34","author":"D Qiao","year":"2025","unstructured":"Qiao, D. et al. The possible effect of inflammation on non-suicidal self-injury in adolescents with depression: a mediator of connectivity within corticostriatal reward circuitry. Eur. Child Adolesc. Psychiatry 34, 1\u201315 (2025).","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"711_CR50","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1093\/schbul\/sbaa136","volume":"47","author":"AH Al-Dujaili","year":"2021","unstructured":"Al-Dujaili, A. H., Mousa, R. F., Al-Hakeim, H. K. & Maes, M. High mobility group Protein 1 and Dickkopf-Related Protein 1 in Schizophrenia and treatment-resistant Schizophrenia: associations with interleukin-6, symptom domains, and neurocognitive impairments. Schizophr. Bull. 47, 530\u2013541 (2021).","journal-title":"Schizophr. Bull."},{"key":"711_CR51","doi-asserted-by":"publisher","first-page":"307","DOI":"10.47162\/RJME.63.2.03","volume":"63","author":"MG N\u0103stase","year":"2022","unstructured":"N\u0103stase, M. G., Vlaicu, I. & Trifu, S. C. Genetic polymorphism and neuroanatomical changes in schizophrenia. Rom. J. Morphol. Embryol. 63, 307\u2013322 (2022).","journal-title":"Rom. J. Morphol. Embryol."},{"key":"711_CR52","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.bbi.2021.07.025","volume":"97","author":"L Fern\u00e1ndez de Coss\u00edo","year":"2021","unstructured":"Fern\u00e1ndez de Coss\u00edo, L. et al. Lipopolysaccharide-induced maternal immune activation modulates microglial CX3CR1 protein expression and morphological phenotype in the hippocampus and dentate gyrus, resulting in cognitive inflexibility during late adolescence. Brain Behav. Immun. 97, 440\u2013454 (2021).","journal-title":"Brain Behav. Immun."},{"key":"711_CR53","doi-asserted-by":"crossref","unstructured":"Nava, R. G. et al. Modulation of neuroimmune cytokine networks by antidepressants: implications in mood regulation. Transl. Psychiatry 15, 314 (2025).","DOI":"10.1038\/s41398-025-03532-y"},{"key":"711_CR54","doi-asserted-by":"publisher","first-page":"1110087","DOI":"10.3389\/fnagi.2023.1110087","volume":"15","author":"Z-G Wu","year":"2023","unstructured":"Wu, Z.-G. et al. Effect of acupuncture on neuroinflammation in animal models of Alzheimer\u2019s disease: a preclinical systematic review and meta-analysis.Front. Aging Neurosci 15, 1110087 (2023).","journal-title":"Front. Aging Neurosci"},{"key":"711_CR55","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jpsychires.2019.05.008","volume":"115","author":"A Shafer","year":"2019","unstructured":"Shafer, A. & Dazzi, F. Meta-analysis of the positive and Negative Syndrome Scale (PANSS) factor structure. J. Psychiatr. Res. 115, 113\u2013120 (2019).","journal-title":"J. Psychiatr. Res."},{"key":"711_CR56","doi-asserted-by":"publisher","first-page":"113054","DOI":"10.1016\/j.psychres.2020.113054","volume":"290","author":"S Sakanaka","year":"2020","unstructured":"Sakanaka, S., Tsujii, N., Morimoto, H. & Shirakawa, O. Aggressiveness is associated with excitement on the five-factor model of the positive and negative syndrome scale and prefrontal function in patients with stable schizophrenia. Psychiatry Res. 290, 113054 (2020).","journal-title":"Psychiatry Res."},{"key":"711_CR57","doi-asserted-by":"crossref","unstructured":"Lim, K. et al. Large-scale evaluation of the Positive and Negative Syndrome Scale (PANSS) symptom architecture in schizophrenia. Asian J. Psychiatry 62, 102732 (2021).","DOI":"10.1016\/j.ajp.2021.102732"},{"key":"711_CR58","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jpsychires.2024.06.008","volume":"176","author":"P Chen","year":"2024","unstructured":"Chen, P. et al. Decreased serum VEGF and NRG1\u03b21 levels in male patients with chronic schizophrenia: VEGF correlation with clinical symptoms and cognitive deficits. J. Psychiatr. Res. 176, 85\u201392 (2024).","journal-title":"J. Psychiatr. Res."}],"container-title":["Schizophrenia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41537-025-00711-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41537-025-00711-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41537-025-00711-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T05:07:56Z","timestamp":1768367276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41537-025-00711-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["711"],"URL":"https:\/\/doi.org\/10.1038\/s41537-025-00711-0","relation":{},"ISSN":["2754-6993"],"issn-type":[{"value":"2754-6993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"19 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}